CapMan to acquire Pharmia

The deal is the second investment from CapMan Buyout XI, which held a first close in June 2019 on €160m and has a target of €250m.

Partner Anders Björkell said the GP had been following the development of the food supplements and medical devices industry for a long time.

The PE firm plans to accelerate the company's growth organically and through M&A.

The transaction is expected to close by the end of March 2021.

Company
Founded in 1993 and based in Tuusula, Finland, Pharmia specialises in contract manufacturing and services. It started out in the pharmaceutical industry, but now focuses on the development and manufacturing of food supplements and CE-marked medical devices, such as vitamins and minerals and probiotics, as well as CE-marked flu treatment products.

The company has a turnover of €16m and employs 90 staff.

People
Pharmia – Hannu Vakkari (CEO); Kari Pulkkinen (board chairman).
CapMan – Anders Björkell (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Nordics
• Consumer
• Finland
• CapMan
• Mid-market buyout